California Resources Corp

7 days ago · zacks.com

California Resources (CRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

13 days ago · globenewswire.com

– Personalized Cancer Detection provides flexible approach to cover multiple types of cancer screening in a single blood draw – – In an independent cohort, SimpleScreen Lung showed 85% sensitivity at 50% specificity and a 99.8% negative predictive value for lung cancer in its intended use population – BRISBANE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Freenome, Inc. (Nasdaq: FRNM), an early cancer detection company developing blood-based tests, today announced the launch of SimpleScreen™ Lung and a first-of-its-kind offering that enables eligible patients to be screened for both lung and colorectal cancer (CRC) through a single blood draw, using two independently validated, indication-specific tests.

18 days ago · businesswire.com

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators presented new data showing the critical role of blood-based testing in increasing overall colorectal cancer (CRC) screening and follow-up colonoscopy adherence at the American College of Gastroenterology (ACG) 2026 Annual Meeting in Nashville, Tennessee. A modeling study looking at individuals 45 to 75 over a lifetime projected.

20 days ago · newsfilecorp.com

Vancouver, British Columbia--(Newsfile Corp. - October 13, 2026) - Canter Resources Corp. (CSE: CRC) (OTC Pink: CNRCF) (FSE: 6O10) ("Canter" or the "Company") announces that it has granted 700,000 incentive stock options to certain directors, officers, advisors and consultants, exercisable at $0.20 per share, for a period of five (5) years from the date of grant. Fifty (50) percent of the options will vest immediately, and the remaining 50 percent will vest in 12 months.

20 days ago · zacks.com

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

26 days ago · globenewswire.com

LONG BEACH, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) plans to release its third quarter 2026 financial results on Monday, November 2nd after market hours.

1 month ago · prnewswire.com

Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal cancer screening options, giving healthcare providers more ways to help eligible patients get screened1-3 SimpleScreen CRC expands screening options for adults age 45 and older, providing another way to help reach people who otherwise may remain unscreened SimpleScreen CRC is covered by Medicare, with no out-of-pocket costs for eligible patients with Medicare Part B ABBOTT PARK, Ill., Sept. 30, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S. commercial launch of SimpleScreen™ CRC, an FDA-approved blood-based colorectal cancer (CRC) screening test for adults age 45 and older who are at average risk for the disease.

1 month ago · seekingalpha.com

Freenome is rated Buy, leveraging FDA-approved SimpleScreen CRC and a $410M cash reserve to target the vast unscreened colorectal market. FRNM's SimpleScreen CRC, now out-licensed to Abbott, offers a patient-friendly, blood-based alternative, with up to $700M in milestone payments and 10% royalties. Upcoming catalysts include the pivotal PROACT LUNG study for SimpleScreen Lung, which could validate the multiomics platform across multiple indications.

2 months ago · zacks.com

CRC plans to sell its non-core Uinta Basin assets for about $90 million, freeing cash to support its California-focused strategy and capital allocation.

2 months ago · globenewswire.com

LONG BEACH, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) today announced the signing of an agreement to divest its Uinta Basin assets to an undisclosed buyer for total cash consideration of approximately $90 million, subject to customary purchase price adjustments.